Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.
about
Isocitrate dehydrogenases in physiology and cancer: biochemical and molecular insight.Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients.Current status of poly(ADP-ribose) polymerase inhibitors and future directions.Wild-type and mutated IDH1/2 enzymes and therapy responses.Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities.Current therapeutic approaches to diffuse grade II and III gliomas.Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates.Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.Evaluating In Vitro DNA Damage Using Comet Assay.Radiosensitization Effect of Talazoparib, a Parp Inhibitor, on Glioblastoma Stem Cells Exposed to Low and High Linear Energy Transfer Radiation.Double-barreled gun: Combination of PARP inhibitor with conventional chemotherapy.Metabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities.Mutant IDH1 Promotes Glioma Formation In Vivo.Modeling the diffusion of D-2-hydroxyglutarate from IDH1 mutant gliomas in the central nervous system.Potential Strategies Overcoming the Temozolomide Resistance for GlioblastomaBridging Cancer Biology with the Clinic: Comprehending and Exploiting IDH Gene Mutations in Gliomas
P2860
Q41247181-50790E84-BCDE-477A-9648-6ADB4FF9578AQ47097853-07934B4F-55C6-4FFB-BD4F-E4977099F307Q47155297-FCBBF6B2-B7EF-4257-B19B-99E1BE1DCE38Q47713415-F3844C9A-5817-4EA6-B32F-465BA11DF5BDQ47989563-4EFFCC6A-1974-4A51-BFAF-F40EA2B6AB99Q49317056-40014022-C129-4ADD-94E8-BBB166FB764EQ49835155-CBE67CB9-8634-48BD-8DCB-0C2BB5E86209Q50033966-5DD5117B-DC4E-42B6-953A-6A5715E2675CQ50061350-1BC3C6B1-702C-4233-8930-E79DFCD9688BQ51747262-0EFBD8A4-0E33-41FE-8F26-91DC2045F54DQ52604402-21604562-83AD-4784-A71F-D98C6B3BF25AQ52716898-DFDBBDDB-1338-4176-8ADD-C56579B72FFCQ55457207-8A22729D-F2B4-4CC4-BE7E-91A57B9593A9Q55457298-EB44BEF1-C852-4946-8E25-777B32C6B2AFQ57153312-4927A705-0C98-4726-8C08-B65F2F8D2B98Q58766030-D2CF8F49-4965-4B52-AEE3-EAC0B9D2D720
P2860
Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Chemosensitivity of IDH1-Mutat ...... in PARP1-Mediated DNA Repair.
@en
type
label
Chemosensitivity of IDH1-Mutat ...... in PARP1-Mediated DNA Repair.
@en
prefLabel
Chemosensitivity of IDH1-Mutat ...... in PARP1-Mediated DNA Repair.
@en
P2093
P2860
P1433
P1476
Chemosensitivity of IDH1-Mutat ...... in PARP1-Mediated DNA Repair.
@en
P2093
Jakub Kwintkiewicz
Jeffrey MacDonald
Katherine Tech
Lauren N Frady
Mark R Gilbert
Matthew G Ewend
Seog In Moon
P2860
P304
P356
10.1158/0008-5472.CAN-16-2773
P407
P577
2017-02-15T00:00:00Z